Ana Maria Gonzalez-Angulo
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston
USA
Name/email consistency: high
- Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer. Gonzalez-Angulo, A.M., Chen, H., Karuturi, M.S., Chavez-MacGregor, M., Tsavachidis, S., Meric-Bernstam, F., Do, K.A., Hortobagyi, G.N., Thompson, P.A., Mills, G.B., Bondy, M.L., Blumenschein, G.R. Cancer (2013)
- Everolimus in the treatment of hormone receptor-positive breast cancer. Chavez-Macgregor, M., Gonzalez-Angulo, A.M. Expert. Opin. Investig. Drugs (2012)
- Targeting the PI3K signaling pathway in cancer therapy. Bartholomeusz, C., Gonzalez-Angulo, A.M. Expert Opin. Ther. Targets (2012)
- PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer. Gonzalez-Angulo, A.M., Ferrer-Lozano, J., Stemke-Hale, K., Sahin, A., Liu, S., Barrera, J.A., Burgues, O., Lluch, A.M., Chen, H., Hortobagyi, G.N., Mills, G.B., Meric-Bernstam, F. Mol. Cancer Ther. (2011)
- Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. Hernandez-Aya, L.F., Chavez-Macgregor, M., Lei, X., Meric-Bernstam, F., Buchholz, T.A., Hsu, L., Sahin, A.A., Do, K.A., Valero, V., Hortobagyi, G.N., Gonzalez-Angulo, A.M. J. Clin. Oncol. (2011)
- Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Gonzalez-Angulo, A.M., Hennessy, B.T., Meric-Bernstam, F., Sahin, A., Liu, W., Ju, Z., Carey, M.S., Myhre, S., Speers, C., Deng, L., Broaddus, R., Lluch, A., Aparicio, S., Brown, P., Pusztai, L., Symmans, W.F., Alsner, J., Overgaard, J., Borresen-Dale, A.L., Hortobagyi, G.N., Coombes, K.R., Mills, G.B. Clin. Proteomics (2011)
- Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer. Hernandez-Aya, L.F., Gonzalez-Angulo, A.M. Oncologist (2011)
- Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Gonzalez-Angulo, A.M., Timms, K.M., Liu, S., Chen, H., Litton, J.K., Potter, J., Lanchbury, J.S., Stemke-Hale, K., Hennessy, B.T., Arun, B.K., Hortobagyi, G.N., Do, K.A., Mills, G.B., Meric-Bernstam, F. Clin. Cancer Res. (2011)
- Metformin: a therapeutic opportunity in breast cancer. Gonzalez-Angulo, A.M., Meric-Bernstam, F. Clin. Cancer Res. (2010)
- High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. Gonzalez-Angulo, A.M., Litton, J.K., Broglio, K.R., Meric-Bernstam, F., Rakkhit, R., Cardoso, F., Peintinger, F., Hanrahan, E.O., Sahin, A., Guray, M., Larsimont, D., Feoli, F., Stranzl, H., Buchholz, T.A., Valero, V., Theriault, R., Piccart-Gebhart, M., Ravdin, P.M., Berry, D.A., Hortobagyi, G.N. J. Clin. Oncol. (2009)
- Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer. Gonzalez-Angulo, A.M., Stemke-Hale, K., Palla, S.L., Carey, M., Agarwal, R., Meric-Berstam, F., Traina, T.A., Hudis, C., Hortobagyi, G.N., Gerald, W.L., Mills, G.B., Hennessy, B.T. Clin. Cancer Res. (2009)
- Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer. Gonzalez-Angulo, A.M., Walters, R., Broglio, K., Frye, D.K., Strom, E.A., Theriault, R.L., Booser, D.J., Valero, V., Buzdar, A.U., Hortobagyi, G.N. Clin. Breast Cancer (2008)
- Trends for inflammatory breast cancer: is survival improving?. Gonzalez-Angulo, A.M., Hennessy, B.T., Broglio, K., Meric-Bernstam, F., Cristofanilli, M., Giordano, S.H., Buchholz, T.A., Sahin, A., Singletary, S.E., Buzdar, A.U., Hortobágyi, G.N. Oncologist (2007)
- Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer. Gonzalez-Angulo, A.M., Hortobágyi, G.N., Esteva, F.J. Oncologist (2006)
- Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer. Gonzalez-Angulo, A.M., Guarneri, V., Gong, Y., Cristofanilli, M., Morales-Vasquez, F., Sneige, N., Hortobagyi, G.N., Esteva, F.J. Clin. Breast Cancer (2006)
- Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Gonzalez-Angulo, A.M., Sahin, A., Krishnamurthy, S., Yang, Y., Kau, S.W., Hortobagyi, G.N., Cristofanilli, M. Clin. Breast Cancer (2006)
- Women age < or = 35 years with primary breast carcinoma: disease features at presentation. Gonzalez-Angulo, A.M., Broglio, K., Kau, S.W., Eralp, Y., Erlichman, J., Valero, V., Theriault, R., Booser, D., Buzdar, A.U., Hortobagyi, G.N., Arun, B. Cancer (2005)
- Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. Gonzalez-Angulo, A.M., McGuire, S.E., Buchholz, T.A., Tucker, S.L., Kuerer, H.M., Rouzier, R., Kau, S.W., Huang, E.H., Morandi, P., Ocana, A., Cristofanilli, M., Valero, V., Buzdar, A.U., Hortobagyi, G.N. J. Clin. Oncol. (2005)
- Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment. Gonzalez-Angulo, A.M., Cristofanilli, M., Strom, E.A., Buzdar, A.U., Kau, S.W., Broglio, K.R., Smith, T.L., Hortobagyi, G.N. Cancer (2004)
